戻る Agenda
Session 3: Science of Literature Surveillance & Technology Roadmap’
Session Chair(s)
Vijay Bhargav
Vice President, Lifecycle Safety
IQVIA, India
Literature is one of the key sources of adverse event reporting and has historically been one of the most complicated processes and perhaps that why underserved by technology. In addition, unique local and regional requirements make this further complex. In this session we will highlight below topics as few of current and potential challenges and discuss experience and suggested solutions.
- Literature Screening and use of Tech initiative for process optimization
- MLM (Medical Literature Monitoring)- Potentially the most sorted process yet the most complicated process
- Literature Best Practices and Local literature screening- How much is good.
Speaker(s)
Literature Best Practices and Local literature screening- How much is good
Kanchan Kanitkar
Labcorp Drug Development India Pvt Ltd. , India
Sr. Manager and Literature SME - Patient Safety Solution
Monitoring of Medical Literature (MLM)
Vaibhav Budhiraja
Paraxel, India
Senior Manager - PV Operations
Literature Screening – Tech initiatives for optimization
Srikanth S, MPHARM
IQVIA, India
Associate Director, Head - SARA Literature center, Life Cycle Safety